Evaluating the clinical efficacy of Apixaban vs. Warfarin in patients with cerebral venous thrombosis (CVT)
Phase 4
Recruiting
- Conditions
- Cerebral venous thrombosis.Cerebral infarction due to cerebral venous thrombosis, nonpyogenicI63.6
- Registration Number
- IRCT20240217061039N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
All patients over 18 years of age who are diagnosed with CVT in imaging
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method